News
Get in Touch
Our Locations
Q² Solutions’ next-generation single cell RNA sequencing methodology: increasing throughput with enhanced high quality assessments
Leveraging industry-leading technologies 10x Genomics® Chromium and Illumina® NovaSeq™ platforms and novel workflows to efficiently meet individual sequencing needs for sponsorsQ² Solutions to Share Key Insights in Bioanalytics Innovation to Optimize Processes at PharmSci 360 Annual Meeting
Expert insights shed light on best practices in bioanalytical services from efficient workflow models to advancements in technologies and platformsQ² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration with Tasso
RESEARCH TRIANGLE PARK, N.C. – Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first...Q² Solutions Present State-of-the-Art Techniques for Bioanalytical Services at 16th Annual Workshop on Recent Issues in Bioanalysis
Through novel workflows and methodologies, expert teams enhance solutions for signature peptide selection and a promising cardiovascular disease biomarker.A day filled with success and a great deal of pride at our laboratory in Livingston, Scotland!
We were honored to host Humza Yousaf, the Health and Social Care Secretary for the Scottish Government, for the official launch of the expanded laboratory campus, which was partially funded by...Q² Solutions Beijing joins CEPI’s global network of COVID-19 vaccine testing labs
Research Triangle Park, N.C. – November 2, 2021 – The Coalition for Epidemic Preparedness Innovations (CEPI) and Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading clinical trial...IQVIA Announces Opening of New Q² Solutions Innovation Laboratories in North Carolina
Creating New Jobs and Expanded Capabilities RESEARCH TRIANGLE PARK, N.C. – October 6, 2021 – IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research...Q² Solutions Undertakes Significant Expansion of Laboratory Operations in Scotland, UK
MORRISVILLE, N.C., June 14, 2021 – Q2 Solutions, a leading global clinical trial laboratory services organization and a wholly owned subsidiary of IQVIA, has announced the expansion of its laboratory...Q² Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
Morrisville, N.C. – June 8, 2021 – Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, today announced a transformative collaboration with...